US12606818B2: Illumina Granted, Nucleic Acid Sequencing Methods
Summary
The USPTO granted US Patent 12,606,818B2 to Illumina, Inc. on April 21, 2026. The patent covers methods and compositions for preparing nucleic acid templates and obtaining sequence data therefrom, with 29 claims. The application was filed on January 12, 2023.
What changed
The USPTO issued Patent 12,606,818B2 to Illumina, Inc. covering nucleic acid sequencing methods and compositions. The patent includes 29 claims relating to nucleic acid template preparation and sequence data acquisition.
For entities developing or commercializing nucleic acid sequencing technologies, this patent represents an intellectual property consideration. Licensing or design-around analysis may be warranted to assess freedom to operate in this technology space.
Archived snapshot
Apr 21, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Methods and compositions for nucleic acid sequencing
Grant US12606818B2 Kind: B2 Apr 21, 2026
Assignee
Illumina, Inc.
Inventors
Frank J. Steemers, Sasan Amini, Kevin L. Gunderson, Natasha Pignatelli, Igor Goryshin
Abstract
Embodiments of the present invention relate to sequencing nucleic acids. In particular, embodiments of the methods and compositions provided herein relate to preparing nucleic acid templates and obtaining sequence data therefrom.
CPC Classifications
C12N 15/1065 C12Q 1/6806 C12Q 1/6869
Filing Date
2023-01-12
Application No.
18153653
Claims
29
Mentioned entities
Parties
Related changes
Get daily alerts for USPTO Patent Grants - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.